Literature DB >> 29187564

A Comparison of Aspergillus and Mucorales PCR Testing of Different Bronchoalveolar Lavage Fluid Fractions from Patients with Suspected Invasive Pulmonary Fungal Disease.

Jan Springer1, P Lewis White2, Johanna Kessel3, Imke Wieters3, Daniel Teschner4, Daniel Korczynski4, Tobias Liebregts5, Oliver A Cornely6, Stefan Schwartz7, Thomas Elgeti8, Lisa Meintker9, Stefan W Krause9, Raquel B Posso2, Werner J Heinz1, Sandra Fuhrmann10,11, Jörg Janne Vehreschild10,11, Hermann Einsele1, Volker Rickerts12, Juergen Loeffler13.   

Abstract

In patients with hematological malignancies, bronchoalveolar lavage fluid (BALF) specimens are commonly used for the diagnosis of mold infections. However, it is not clear whether the cell pellet (P) or the supernatant fraction (S) of the BALF specimen is optimal for molecular diagnostic testing. Thus, 99 BALF specimens were collected from 96 hematology patients with or without allogeneic hematopoietic stem cell transplant. The cell pellets and supernatants were processed alone and in combination (S/P) for testing by two fungus-specific real-time PCR assays compliant with international recommendations. The results achieved with S/P were revealed to be superior in comparison to those achieved with S and P alone, with the use of each single fraction showing a reduced sensitivity for the detection of Aspergillus DNA (82% and 43% for S and P, respectively). In 57% of the samples, testing of the combination of S and P generated a lower quantification cycle value than testing of S or P alone. Molds would have been missed in 5 and 16 out of 28 samples if only S or P, respectively, was analyzed. No sample was positive by testing of S or P only. Similar results were obtained for the detection of Mucorales DNA in BALF specimens (reduced sensitivity of 67% and 50% for S and P, respectively). Study patients were categorized according to the current European Organization for the Research and Treatment of Cancer/Mycoses Study Group classification for invasive fungal disease (IFD), revealing that 35 patients had proven/probable IFD (36%), 47 patients had possible IFD (49%), and 14 patients had undetermined IFD (15%).
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  Aspergillus; Mucorales; PCR; bronchoalveolar lavage fluid; mold; pellet; supernatant

Mesh:

Substances:

Year:  2018        PMID: 29187564      PMCID: PMC5786722          DOI: 10.1128/JCM.01655-17

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  20 in total

1.  Development and application of two independent real-time PCR assays to detect clinically relevant Mucorales species.

Authors:  Jan Springer; Daniel Goldenberger; Friderike Schmidt; Maja Weisser; Elisabeth Wehrle-Wieland; Hermann Einsele; Reno Frei; Jürgen Löffler
Journal:  J Med Microbiol       Date:  2016-01-07       Impact factor: 2.472

Review 2.  Diagnostic accuracy of PCR alone compared to galactomannan in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis: a systematic review.

Authors:  Tomer Avni; Itzhak Levy; Hannah Sprecher; Dafna Yahav; Leonard Leibovici; Mical Paul
Journal:  J Clin Microbiol       Date:  2012-09-05       Impact factor: 5.948

3.  Evaluation of Aspergillus PCR protocols for testing serum specimens.

Authors:  P Lewis White; Carlo Mengoli; Stéphane Bretagne; Manuel Cuenca-Estrella; Niklas Finnstrom; Lena Klingspor; Willem J G Melchers; Elaine McCulloch; Rosemary A Barnes; J Peter Donnelly; Juergen Loeffler
Journal:  J Clin Microbiol       Date:  2011-09-21       Impact factor: 5.948

4.  Pathogen-specific DNA enrichment does not increase sensitivity of PCR for diagnosis of invasive aspergillosis in neutropenic patients.

Authors:  Jan Springer; Juergen Loeffler; Werner Heinz; Hannes Schlossnagel; Marc Lehmann; Oliver Morton; Thomas R Rogers; Corinna Schmitt; Matthias Frosch; Hermann Einsele; Oliver Kurzai
Journal:  J Clin Microbiol       Date:  2010-12-29       Impact factor: 5.948

5.  Estimating the burden of invasive and serious fungal disease in the United Kingdom.

Authors:  Matthew Pegorie; David W Denning; William Welfare
Journal:  J Infect       Date:  2016-10-24       Impact factor: 6.072

6.  Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy.

Authors:  W Garrett Nichols; Katherine A Guthrie; Lawrence Corey; Michael Boeckh
Journal:  Clin Infect Dis       Date:  2004-10-11       Impact factor: 9.079

7.  Prospective multicentre PCR-based Aspergillus DNA screening in high-risk patients with and without primary antifungal mould prophylaxis.

Authors:  J Springer; M Lackner; D Nachbaur; M Girschikofsky; B Risslegger; W Mutschlechner; J Fritz; W J Heinz; H Einsele; A J Ullmann; J Löffler; C Lass-Flörl
Journal:  Clin Microbiol Infect       Date:  2015-09-21       Impact factor: 8.067

8.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.

Authors:  Ben De Pauw; Thomas J Walsh; J Peter Donnelly; David A Stevens; John E Edwards; Thierry Calandra; Peter G Pappas; Johan Maertens; Olivier Lortholary; Carol A Kauffman; David W Denning; Thomas F Patterson; Georg Maschmeyer; Jacques Bille; William E Dismukes; Raoul Herbrecht; William W Hope; Christopher C Kibbler; Bart Jan Kullberg; Kieren A Marr; Patricia Muñoz; Frank C Odds; John R Perfect; Angela Restrepo; Markus Ruhnke; Brahm H Segal; Jack D Sobel; Tania C Sorrell; Claudio Viscoli; John R Wingard; Theoklis Zaoutis; John E Bennett
Journal:  Clin Infect Dis       Date:  2008-06-15       Impact factor: 9.079

9.  Estimated burden of fungal infections in Germany.

Authors:  Markus Ruhnke; Andreas H Groll; Peter Mayser; Andrew J Ullmann; Werner Mendling; Herbert Hof; David W Denning
Journal:  Mycoses       Date:  2015-10       Impact factor: 4.377

Review 10.  Diagnostic Evaluation of Pulmonary Abnormalities in Patients with Hematologic Malignancies and Hematopoietic Cell Transplantation.

Authors:  Bianca Harris; Alexander I Geyer
Journal:  Clin Chest Med       Date:  2017-06       Impact factor: 2.878

View more
  7 in total

1.  Use of Aspergillus fumigatus real-time PCR in bronchoalveolar lavage samples (BAL) for diagnosis of invasive aspergillosis, including azole-resistant cases, in high risk haematology patients: the need for a combined use with galactomannan.

Authors:  Malgorzata Mikulska; Elisa Furfaro; Elena De Carolis; Enrico Drago; Ilaria Pulzato; Maria Lucia Borghesi; Emanuela Zappulo; Anna Maria Raiola; Carmen Di Grazia; Valerio Del Bono; Giuseppe Cittadini; Emanuele Angelucci; Maurizio Sanguinetti; Claudio Viscoli
Journal:  Med Mycol       Date:  2019-11-01       Impact factor: 4.076

2.  Genotyping of Aspergillus fumigatus in Formalin-Fixed Paraffin-Embedded Tissues and Serum Samples From Patients With Invasive Aspergillosis.

Authors:  Theun de Groot; Ferry Hagen; Willem Vreuls; Paul E Verweij; Anuradha Chowdhary; Jacques F Meis
Journal:  Front Cell Infect Microbiol       Date:  2018-10-23       Impact factor: 5.293

3.  Special Staining of the Liquid-Based Cytopathology Test in Bronchoalveolar Lavage Fluid for Diagnosis of Invasive Pulmonary Aspergillosis with Nonneutropenic Patients.

Authors:  Yue Hu; Lin Zheng; Deng Pan; Lei Shao; Xianfa Xu; Yiming Yu; Qidong Zhuang; Zaichun Deng; Zhongbo Chen
Journal:  Can Respir J       Date:  2020-03-31       Impact factor: 2.409

4.  Detection of Fusarium Species in Clinical Specimens by Probe-Based Real-Time PCR.

Authors:  Jan Springer; Grit Walther; Volker Rickerts; Axel Hamprecht; Birgit Willinger; Daniel Teschner; Hermann Einsele; Oliver Kurzai; Juergen Loeffler
Journal:  J Fungi (Basel)       Date:  2019-11-12

5.  Comparing the application of mNGS after combined pneumonia in hematologic patients receiving hematopoietic stem cell transplantation and chemotherapy: A retrospective analysis.

Authors:  Binglei Zhang; Ruirui Gui; Qian Wang; Xueli Jiao; Zhen Li; Juan Wang; Lu Han; Ling Zhou; Huili Wang; Xianjing Wang; Xinxin Fan; Xiaodong Lyu; Yongping Song; Jian Zhou
Journal:  Front Cell Infect Microbiol       Date:  2022-09-21       Impact factor: 6.073

Review 6.  Recent advances in the understanding and management of mucormycosis.

Authors:  Benoit Pilmis; Alexandre Alanio; Olivier Lortholary; Fanny Lanternier
Journal:  F1000Res       Date:  2018-09-07

Review 7.  Epidemiology and Diagnosis of Mucormycosis: An Update.

Authors:  Anna Skiada; Ioannis Pavleas; Maria Drogari-Apiranthitou
Journal:  J Fungi (Basel)       Date:  2020-11-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.